Cairo - Mubasher: Kahira Pharmaceuticals said that Abbott Laboratories has supplied a new assembly line to produce Brufen syrup at its own cost.
The company said in a statement to the Egyptian Exchange (EGX) on Monday that the product will be sold to Abbott for a margin of the profits, noting that production and selling will be as per the demand of Abbott.
Kahira Pharmaceuticals targets an increase in net profits by 17% in the preliminary budget for fiscal year 2016-2017.
